What Are Basal Cells? Skin Role and Cancer Risk

Basal cells are the small, round cells that form the deepest layer of your outer skin, sitting right at the boundary between the epidermis and the tissue beneath it. They are the skin’s primary regenerators, constantly dividing to produce the fresh cells that eventually become the tough, protective surface you see and touch. That regenerative role also makes them vulnerable: when their DNA accumulates damage, particularly from ultraviolet light, basal cells can give rise to basal cell carcinoma, the single most common cancer in people of European descent. The biology of these cells explains both how your skin stays intact every day and why it sometimes doesn’t.

Where Basal Cells Live

Your skin’s outer layer, the epidermis, is built in tiers. The deepest tier is a single row of cells called the basal layer, and these are your basal cells, also known as basal keratinocytes. They sit on a thin sheet of structural proteins called the basement membrane, which separates them from the dermis below. Early in embryonic development, surface cells commit to becoming this basal layer and begin expressing a characteristic pair of structural proteins, keratin 5 and keratin 14, that serve as reliable identity markers for basal cells throughout life.¹ These keratins are produced in actively dividing basal cells and get switched off as cells mature and move upward through the epidermis.²

Once a basal cell divides, one daughter cell stays put to keep the basal layer stocked, while the other begins migrating upward. As it rises, it flattens, hardens, loses its nucleus, and eventually becomes part of the outermost dead layer of skin that sheds continuously. This entire journey from fresh basal cell to shed surface cell takes roughly a month in healthy adult skin, and it repeats indefinitely throughout your life.

How Basal Cells Anchor the Skin

Staying firmly attached to the basement membrane is arguably as important as dividing. Two specialized structures handle this job: hemidesmosomes and focal adhesions. Hemidesmosomes are protein complexes that rivet basal cells to the membrane beneath them, providing the stable grip that keeps the epidermis from shearing away under friction or pressure.³ Focal adhesions are more dynamic, able to tighten or loosen their hold as the cell responds to signals from its environment. Together, these anchoring systems maintain the skin’s barrier against outside threats and support the ongoing self-renewal that keeps the epidermis healthy.⁴

When these attachment structures weaken, the consequences are real. Genetic disorders that disrupt hemidesmosomes cause blistering diseases, where the epidermis separates from the dermis with minimal trauma. And as people age, the same anchoring machinery gradually degrades, contributing to the fragile, more easily damaged skin older adults experience.

Protecting DNA From Sunlight

Basal cells sit at the bottom of the epidermis, which gives them some built-in distance from the sun. But UV light still reaches them, and because they are the dividing cells, DNA damage here matters far more than damage in the disposable cells above. If a surface cell picks up a UV-induced mutation, it will be shed within weeks. If a basal cell picks one up, that mutation can be copied into every daughter cell it produces for years.

The skin has a defense against this. Melanocytes, the pigment-producing cells scattered among basal keratinocytes, manufacture melanin and transfer it to neighboring cells. Inside those keratinocytes, the melanin clusters above the nucleus like a tiny parasol, forming what researchers call a supranuclear melanin cap.⁵ This cap physically blocks UV photons from hitting the DNA below it, reducing the formation of the specific DNA damage products that UV light causes.⁶ People with more melanin get more protection, which is a major reason skin cancer rates differ so dramatically across skin types.

Basal Cells in Wound Healing

When skin is broken, basal cells are among the first responders. Within about a day of an injury, basal keratinocytes at the wound edges begin migrating into the wound bed to start rebuilding the epidermis.⁷ They do this before any new cells are produced; the initial coverage comes from existing basal cells crawling across the exposed area. Research on partial-thickness wounds shows that basal keratinocytes move as a sheet of independently migrating cells, constantly rearranging themselves to slip around intact obstacles in the wound bed.⁸ The more superficial, differentiated cells above them contribute little to this process.

Meanwhile, basal cells in the intact skin surrounding the wound ramp up their rate of division to produce reinforcements.⁹ This combination of migration first, proliferation second is the basic blueprint for re-epithelialization. It is why shallow scrapes heal quickly with minimal scarring: the basal cells can cover a superficial wound fast. Deeper injuries that destroy the entire epidermis and the basal layer beneath it heal more slowly and scar more, precisely because the cells that would normally lead the repair effort have been lost.

How Basal Cells Become Cancer

Basal cell carcinoma, or BCC, accounts for roughly 80% of all non-melanoma skin cancers and is the most common malignancy in people with lighter skin.¹⁰ It gets its name because the tumor cells resemble basal keratinocytes under the microscope, though the actual cell of origin appears to be a bit more specific than “any basal cell.” Mouse studies using genetic tools to trigger tumor-driving mutations in different cell populations have shown that stem cells within hair follicles and certain nerve-associated niches are especially prone to forming BCC-like growths, while ordinary basal cells between hair follicles are surprisingly resistant.¹¹ This helps explain why BCC tends to show up on hair-bearing skin and why certain spots on the face are more vulnerable than others.

The molecular engine behind most BCCs is a signaling pathway called hedgehog signaling. In normal skin, this pathway helps regulate cell growth during development and then largely quiets down. When mutations lock it into an “on” position, the affected cells keep dividing when they shouldn’t.¹² The gene most commonly mutated is called PTCH1, which normally acts as a brake on the pathway. Lose that brake, and the cells grow unchecked.

The Role of UV Damage

Ultraviolet radiation is the dominant environmental cause of BCC. UVB light in particular directly damages DNA in basal keratinocytes, creating abnormal chemical bonds between adjacent DNA bases. These lesions, if not repaired correctly, produce the characteristic C-to-T mutations that researchers consider a fingerprint of UV-induced cancer.¹³ The TP53 gene, which normally forces damaged cells to stop dividing or self-destruct, is one of the most frequently knocked out genes in BCC, and most of those TP53 mutations carry the UV signature.¹³

What makes this somewhat paradoxical is that BCC, squamous cell carcinoma, and melanoma all involve UV exposure, yet each seems to be driven by different patterns of that exposure and by different molecular pathways inside the cell.¹⁴ BCC correlates strongly with cumulative lifetime sun exposure and tends to appear on chronically sun-exposed areas like the nose, forehead, and ears. Melanoma, by contrast, is more strongly linked to intense intermittent exposure and sunburns, especially in childhood. This is one reason blanket “wear sunscreen” advice, while correct, undersells how differently these cancers behave.

Why BCC Rarely Kills

Despite being extraordinarily common, BCC is rarely life-threatening. It grows slowly, tends to stay local, and almost never spreads to distant organs. Estimates of the metastasis rate range from about 0.003% to 0.55% of all BCC cases, depending on the study population and how metastasis is defined.¹⁵ That is a strikingly low rate for any cancer, and it means the vast majority of BCCs are cured with local treatment.

The danger with BCC is not metastasis but local destruction. Left untreated for years, a BCC on the face can erode through cartilage or bone. Aggressive subtypes, particularly the infiltrative and morpheaform variants, are more likely to invade deeper structures and are harder to remove completely, leading to higher recurrence rates.¹⁶ Most BCCs, though, are the nodular type: a pearly, dome-shaped bump that grows over months or years and is readily treated when caught early.

Gorlin Syndrome and Inherited Risk

Most BCCs are sporadic, meaning they arise from accumulated UV damage over a lifetime. But a rare genetic condition called Gorlin syndrome, or nevoid basal cell carcinoma syndrome, dramatically illustrates what happens when the hedgehog pathway’s brake is broken from birth. People with Gorlin syndrome inherit a faulty copy of the PTCH1 gene, the same gene mutated in most sporadic BCCs, and they begin developing multiple basal cell carcinomas early in life, sometimes in childhood or adolescence.¹⁷

The condition affects roughly 1 in 19,000 people and is inherited in a dominant pattern, meaning only one faulty gene copy is needed.¹⁸ Patients can develop dozens or even hundreds of BCCs over their lifetime and also face a higher risk of other tumors, including a childhood brain tumor called medulloblastoma. Gorlin syndrome is rare, but it underscores the central importance of the hedgehog pathway in BCC biology: the same molecular defect that causes sporadic tumors from UV exposure causes an avalanche of tumors when present from the start.

How BCC Is Treated

Surgery remains the standard of care for most basal cell carcinomas. For straightforward, low-risk tumors, a simple excision with a margin of normal tissue around it is usually curative. For high-risk tumors, especially those on the face where preserving tissue matters, a technique called Mohs micrographic surgery is preferred. In Mohs surgery, the surgeon removes tissue in thin layers and examines each layer under a microscope in real time, stopping only when no tumor cells remain at the margins. This approach offers the highest cure rate while removing the least normal tissue. For select low-risk lesions, non-surgical options such as cryotherapy, topical creams, and photodynamic therapy can also be effective.¹⁹

The treatment landscape shifted when researchers realized they could target the hedgehog pathway directly. Two drugs, vismodegib and sonidegib, block a protein called Smoothened that relays the hedgehog signal inside the cell. These drugs have proven effective for patients with advanced or inoperable BCC.²⁰ The catch is resistance: some tumors develop mutations in Smoothened that prevent the drug from binding, while others activate alternative growth pathways that bypass the hedgehog block altogether.²¹ Research into overcoming that resistance, through drug combinations or switching between inhibitors, is ongoing.

Basal Cells in Other Organs

The term “basal cell” is not exclusive to skin. Several other tissues have their own basal cell populations that play analogous roles. The lining of the airways, the prostate gland, the salivary glands, and the esophagus all contain basal cells that sit at the base of their respective epithelia and serve as progenitors for the more specialized cells above or around them. In the prostate, for instance, basal cells handle regeneration and maintenance of the epithelial lining, while the luminal cells above them carry out the gland’s secretory functions.²²

These non-skin basal cells share some molecular features with their epidermal cousins, including similar keratin expression patterns and a reliance on the same attachment structures. They can also become cancerous: basal-like tumors of the breast, lung, and prostate are all recognized subtypes in those organs. Each has its own biology and behavior, but the underlying theme, a progenitor cell acquiring growth-driving mutations, is consistent.

Aging and Basal Cell Competition

One of the more fascinating recent findings about basal cells is that they compete with each other. Research in mice has shown that individual basal stem cells naturally vary in their levels of a hemidesmosome protein called collagen XVII (COL17A1). Cells with high levels of this protein divide symmetrically and tend to crowd out neighboring cells that have lower levels. This competition actively selects for higher-quality stem cells, keeping the epidermis in good shape during youth.²³

The problem is that all cells eventually lose COL17A1 through accumulated stress and oxidative damage. As the winning competitors themselves start to decline, the overall quality of the stem cell pool drops. The hemidesmosomes weaken, cells detach from the basement membrane more easily, and the neighboring melanocytes and connective tissue cells are depleted along with them. The visible result is thinner, more fragile skin with less pigment, the familiar hallmarks of aged skin. This finding reframes skin aging not just as wear and tear but as the gradual exhaustion of a competitive selection process that once kept the epidermis vigorous.